AstraZeneca | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

A Study Concludes Blood Clots Linked to AstraZeneca Vaccine are ‘Rare but Devastating’

Rebecca Urena08/12/2021

2303

A new study with information regarding the “rare but devastating” blood clotting issue affiliated with the Oxford-AstraZeneca (OTCMKTS: AZNCF) Covid-19 vaccine has been released. Nevertheless, according to British scientists,...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz

AstraZeneca, EU Both Claim to Win Court Case Regarding Vaccine Delivery

Rebecca Urena06/18/2021

3747

AstraZeneca (OTCMKTS: AZNCF) and the European Union (EU) both claim to have won a legal battle in which the EU accused the pharmaceutical company of not producing enough vaccine...

Domestic Healthcare Politics Taxes

Biden Proposes Small Business Tax Credit to Offer Employees Paid Leave for Vaccination

Leeor04/22/2021

4456

President Biden announced that he will be offering a tax credit to small businesses to provide their employees paid leave while getting vaccinated and recovering from any potential side...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Israel Reportedly Attempting to Cancel Astrazeneca Vaccine Order

Leeor04/21/2021

1646

The Israeli Government is reportedly seeking to cancel an order for 10 million doses of the AstraZeneca (NASDAQ: AZN) COVID-19 vaccine. Israel currently leads the world in vaccine rollouts...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Emergent BioSolutions Asked to Halt Covid-Vaccine Production by FDA

Rebecca Urena04/19/2021

2079

Emergent BioSolutions (NYSE: EBS) has been asked by the Food and Drug Administration to stop production for Covid-19 vaccines. According to the company, the halt comes amid a botched...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

Rebecca Urena03/22/2021

2188

A U.S. trial found that AstraZeneca (OTCMKTS: AZNCF) and the University of Oxford’s coronavirus vaccine was 79% effective in preventing the covid-19 virus. Furthermore the vaccine is 100% effective...

Tag: AstraZeneca

A Study Concludes Blood Clots Linked to AstraZeneca Vaccine are ‘Rare but Devastating’

AstraZeneca, EU Both Claim to Win Court Case Regarding Vaccine Delivery

Biden Proposes Small Business Tax Credit to Offer Employees Paid Leave for Vaccination

Israel Reportedly Attempting to Cancel Astrazeneca Vaccine Order

Emergent BioSolutions Asked to Halt Covid-Vaccine Production by FDA

AstraZeneca Vaccine Proves to be 79% Effective in U.S. Trial

ABOUT US

Tweets